OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

RVNC

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Revance Therapeutics (RVNC) Ownership - Who owns Revance Therapeutics?

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Pharmaceuticals Other

Address

1222 Demonbreun Street

Phone

+1 615 724-7755

Employees

597

Web

https://www.revance.com

Details

Group

Domestic Stock Funds

Fundamentals

RVNC

Capitalization

N/A

P/E Ratio

N/A

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

N/A

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

N/A

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

N/A

Shares Outstanding - Current

N/A

Total Liabilities

N/A

Total Volume MTD

N/A

Value

N/A

Gain YTD

N/A

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RVNC (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of drugs

Industry Biotechnology